Global Information
회사소개 | 문의 | 비교리스트

세계의 프로테오믹스 시장 : 용도별, 적응증별, 기술별, 종류별, 제품별, 최종사용자별, 지역별 경쟁, 예측, 기회(2025년)

Global Proteomics Market By Application, By Indication, By Technology, By Type, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 934758
페이지 정보 영문 115 Pages
가격
US $ 4,450 ₩ 5,088,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,231,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,805,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 프로테오믹스 시장 : 용도별, 적응증별, 기술별, 종류별, 제품별, 최종사용자별, 지역별 경쟁, 예측, 기회(2025년) Global Proteomics Market By Application, By Indication, By Technology, By Type, By Product, By End-User, By Region, Competition, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 115 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 프로테오믹스(Proteomics) 시장을 조사했으며, 각 지역 시장 전망, 시장 역학, 주요 동향, 경쟁 상황 등의 정보를 제공하고, 전략적 제안을 제시하고 있습니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 프로테오믹스 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 용도별(Drug Discovery, 진단 바이오마커 발견, 임상 진단, 기타)
    • 적응증별(감염증, 순환기, 신경혈관, 당뇨병, 기타)
    • 기술별
    • 종류별(기능, 표현, 구조, 계산)
    • 제품별(소프트웨어, 기기, 시약 및 어세이, 서비스)
    • 최종사용자별(제약 및 바이오테크놀러지 기업, 조사기관, CRO)
    • 기업별(2019년)
    • 지역별
  • 시장 매력 지수

제5장 아시아태평양의 프로테오믹스 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 용도별
    • 적응증별
    • 기술별
    • 종류별
    • 제품별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 아시아태평양 : 국가 분석
    • 중국의 프로테오믹스 시장 전망
    • 인도의 프로테오믹스 시장 전망
    • 일본의 프로테오믹스 시장 전망
    • 한국의 프로테오믹스 시장 전망
    • 싱가포르의 프로테오믹스 시장 전망
    • 호주의 프로테오믹스 시장 전망

제6장 유럽의 프로테오믹스 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 용도별
    • 적응증별
    • 기술별
    • 종류별
    • 제품별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 유럽 : 국가 분석
    • 프랑스의 프로테오믹스 시장 전망
    • 독일의 프로테오믹스 시장 전망
    • 영국의 프로테오믹스 시장 전망
    • 이탈리아의 프로테오믹스 시장 전망

제7장 북미의 프로테오믹스 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 용도별
    • 적응증별
    • 기술별
    • 종류별
    • 제품별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 북미 : 국가 분석
    • 미국의 프로테오믹스 시장 전망
    • 멕시코의 프로테오믹스 시장 전망
    • 캐나다의 프로테오믹스 시장 전망

제8장 남미의 프로테오믹스 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 용도별
    • 적응증별
    • 기술별
    • 종류별
    • 제품별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 남미 : 국가 분석
    • 브라질의 프로테오믹스 시장 전망
    • 아르헨티나의 프로테오믹스 시장 전망
    • 콜롬비아의 프로테오믹스 시장 전망

제9장 중동과 아프리카의 프로테오믹스 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 용도별
    • 적응증별
    • 기술별
    • 종류별
    • 제품별
    • 최종사용자별
    • 국가별
  • 시장 매력 지수
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국의 프로테오믹스 시장 전망
    • 사우디아라비아의 프로테오믹스 시장 전망
    • UAE의 프로테오믹스 시장 전망

제10장 시장 역학

  • 성장 촉진요인
  • 과제

제11장 시장 동향

제12장 경쟁 상황

  • 경쟁 전망
  • 주요 기업 개요
    • Thermo Fisher Scientific
    • Agilent Technologies
    • Waters Corporation
    • Bio-Rad Laboratories
    • GE Healthcare
    • PerkinElmer
    • Creative Proteomics
    • Luminex Corporation
    • Promega Corporation
    • Caprion
    • Bruker
    • Pfizer
    • Horiba
    • Qiagen
    • Becton Dickinson
    • Bioproximity
    • Biocon
    • Evotec
    • Bristol-Myers Squibb
    • Illumina
    • Takeda Pharmaceuticals

제13장 전략적 제안

제14장 면책사항

KSM 20.06.02

Global proteomics market is expected to grow at a brisk CAGR during the forecast period. The key factor responsible for increased demand for proteomics is due to growing investments in research and development activities in end use industries such as biotechnology sector and pharmaceutical industry. Additionally, increasing demand for personalized medicine is anticipated to bode well for the growth of proteomics market across the globe in the coming years. Moreover, increasing government support in terms of providing funds is anticipated to bolster the market growth through 2025.

The global proteomics market is segmented based on application, indication, technology, type, product, end-user, region and company. Based on application, the market can be segmented into drug discovery, diagnostic biomarker discovery, clinical diagnostic, others. Out of which, the clinical diagnostics segment dominated the market in terms of largest market size until 2019 and is further anticipated to maintain its leading position during the forecast period as well. This growth can be accredited to enhanced knowledge of understanding the patterns of protein expression for disease diagnostics and development of drug. Also, tandem MS and LC are some proteomics technology that are effective for the identification of proteins, thus boosting the growth of the segment across the globe.

Major players operating in the global proteomics market include Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, Bio-Rad Laboratories, GE Healthcare, PerkinElmer, Creative Proteomics, Luminex Corporation, Promega Corporation, Caprion, Bruker, Pfizer, Horiba, Qiagen, Becton Dickinson, Bioproximity, Biocon, Evotec, Bristol-Myers Squibb, Illumina, Takeda Pharmaceuticals, etc. The companies operating in proteomics market across the globe are focussing more towards the expanding their share in the market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyse and forecast the market size of global proteomics market.
  • To classify and forecast global proteomics market based on application, indication, technology, type, product, end-user, company and regional distribution.
  • To identify drivers and challenges for global proteomics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global proteomics market.
  • To conduct pricing analysis for global proteomics market.
  • To identify and analyse the profile of leading players operating in global proteomics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research. TechSci Research analyzed the new products, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global proteomics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Proteomics companies, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to proteomics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global proteomics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Application:

Drug Discovery

Diagnostic Biomarker Discovery

Clinical diagnostic

Others

  • Market, By Indication:

Infectious Disease

Cardiology

Neurovascular

Diabetes

Others

  • Market, By Technology:

Conventional

  • Chromatography
  • ELISA
  • Western blotting

Advanced

  • Protein microarray
  • Gel electrophoresis
  • Mass Spectrophotometry
  • Edman Sequencing

Quantitative

  • Isotope-coded affinity tag labelling
  • Stable isotope labelling with amino acids in cell culture
  • Isobaric tag for relative and absolute quantitation

High-thoroughput

  • X-ray crystallography
  • NMR

Bioinformatic analysis

  • Market, By Type:

Functional

Expression

Structural

Computational

  • Market, By Product:

Software

Instruments

Reagents and Assays

Services

  • Market, By End-User:

Pharmaceutical and biotechnology companies

Research institutes

CROs

  • Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Middle East and Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global proteomics market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Global Proteomics Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value & Volume
  • 4.2. Market Share & Forecast
    • 4.2.1. By Application (Drug Discovery, Diagnostic Biomarker Discovery, Clinical diagnostic, Others)
    • 4.2.2. By Indication (Infectious Disease, Cardiology, Neurovascular, Diabetes, Others)
    • 4.2.3. By Technology
        • 4.2.3.1.1. Conventional (Chromatography (HPLC, Affinity, Others), ELISA, Western blotting)
        • 4.2.3.1.2. Advanced (Protein microarray (Analytical, Functional, Reverse-phase), Gel electrophoresis (2D, Capillary, SDS-PAGE, 2D-DIGE), Mass Spectrophotometry, Edman Sequencing)
        • 4.2.3.1.3. Quantitative (Isotope-coded affinity tag (ICAT) labeling, Stable isotope labeling with amino acids in cell culture (SILAC), Isobaric tag for relative and absolute quantitation (iTRAQ))
        • 4.2.3.1.4. High-thoroughput (X-ray crystallography, NMR)
        • 4.2.3.1.5. Bioinformatic analysis
    • 4.2.4. By Type (Functional, Expression, Structural, Computational)
    • 4.2.5. By Product (Software, Instruments, Reagents and Assays, Services)
    • 4.2.6. By End-User (Pharmaceutical and biotechnology companies, Research institutes, CROs)
    • 4.2.7. By Company (2019)
    • 4.2.8. By Region
  • 4.3. Market Attractiveness Index

5. Asia-Pacific Proteomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application
    • 5.2.2. By Indication
    • 5.2.3. By Technology
    • 5.2.4. By Type
    • 5.2.5. By Product
    • 5.2.6. By End-User
    • 5.2.7. By Country
  • 5.3. Market Attractiveness Index
  • 5.4. Asia-Pacific: Country Analysis
    • 5.4.1. China Proteomics Market Outlook
      • 5.4.1.1. Market Size & Forecast
        • 5.4.1.1.1. By Value
      • 5.4.1.2. Market Share & Forecast
        • 5.4.1.2.1. By Application
        • 5.4.1.2.2. By Indication
        • 5.4.1.2.3. By Technology
        • 5.4.1.2.4. By Type
        • 5.4.1.2.5. By Product
        • 5.4.1.2.6. By End-User
    • 5.4.2. India Proteomics Market Outlook
      • 5.4.2.1. Market Size & Forecast
        • 5.4.2.1.1. By Value
      • 5.4.2.2. Market Share & Forecast
        • 5.4.2.2.1. By Application
        • 5.4.2.2.2. By Indication
        • 5.4.2.2.3. By Technology
        • 5.4.2.2.4. By Type
        • 5.4.2.2.5. By Product
        • 5.4.2.2.6. By End-User
    • 5.4.3. Japan Proteomics Market Outlook
      • 5.4.3.1. Market Size & Forecast
        • 5.4.3.1.1. By Value
      • 5.4.3.2. Market Share & Forecast
        • 5.4.3.2.1. By Application
        • 5.4.3.2.2. By Indication
        • 5.4.3.2.3. By Technology
        • 5.4.3.2.4. By Type
        • 5.4.3.2.5. By Product
        • 5.4.3.2.6. By End-User
    • 5.4.4. South Korea Proteomics Market Outlook
      • 5.4.4.1. Market Size & Forecast
        • 5.4.4.1.1. By Value
      • 5.4.4.2. Market Share & Forecast
        • 5.4.4.2.1. By Application
        • 5.4.4.2.2. By Indication
        • 5.4.4.2.3. By Technology
        • 5.4.4.2.4. By Type
        • 5.4.4.2.5. By Product
        • 5.4.4.2.6. By End-User
    • 5.4.5. Singapore Proteomics Market Outlook
      • 5.4.5.1. Market Size & Forecast
        • 5.4.5.1.1. By Value
      • 5.4.5.2. Market Share & Forecast
        • 5.4.5.2.1. By Application
        • 5.4.5.2.2. By Indication
        • 5.4.5.2.3. By Technology
        • 5.4.5.2.4. By Type
        • 5.4.5.2.5. By Product
        • 5.4.5.2.6. By End-User
    • 5.4.6. Australia Proteomics Market Outlook
      • 5.4.6.1. Market Size & Forecast
        • 5.4.6.1.1. By Value
      • 5.4.6.2. Market Share & Forecast
        • 5.4.6.2.1. By Application
        • 5.4.6.2.2. By Indication
        • 5.4.6.2.3. By Technology
        • 5.4.6.2.4. By Type
        • 5.4.6.2.5. By Product
        • 5.4.6.2.6. By End-User

6. Europe Proteomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Indication
    • 6.2.3. By Technology
    • 6.2.4. By Type
    • 6.2.5. By Product
    • 6.2.6. By End-User
    • 6.2.7. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Europe: Country Analysis
    • 6.4.1. France Proteomics Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Application
        • 6.4.1.2.2. By Indication
        • 6.4.1.2.3. By Technology
        • 6.4.1.2.4. By Type
        • 6.4.1.2.5. By Product
        • 6.4.1.2.6. By End-User
    • 6.4.2. Germany Proteomics Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Application
        • 6.4.2.2.2. By Indication
        • 6.4.2.2.3. By Technology
        • 6.4.2.2.4. By Type
        • 6.4.2.2.5. By Product
        • 6.4.2.2.6. By End-User
    • 6.4.3. United Kingdom Proteomics Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Application
        • 6.4.3.2.2. By Indication
        • 6.4.3.2.3. By Technology
        • 6.4.3.2.4. By Type
        • 6.4.3.2.5. By Product
        • 6.4.3.2.6. By End-User
    • 6.4.4. Italy Proteomics Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Application
        • 6.4.4.2.2. By Indication
        • 6.4.4.2.3. By Technology
        • 6.4.4.2.4. By Type
        • 6.4.4.2.5. By Product
        • 6.4.4.2.6. By End-User

7. North America Proteomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Indication
    • 7.2.3. By Technology
    • 7.2.4. By Type
    • 7.2.5. By Product
    • 7.2.6. By End-User
    • 7.2.7. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. North America: Country Analysis
    • 7.4.1. United States Proteomics Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Application
        • 7.4.1.2.2. By Indication
        • 7.4.1.2.3. By Technology
        • 7.4.1.2.4. By Type
        • 7.4.1.2.5. By Product
        • 7.4.1.2.6. By End-User
    • 7.4.2. Mexico Proteomics Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Application
        • 7.4.2.2.2. By Indication
        • 7.4.2.2.3. By Technology
        • 7.4.2.2.4. By Type
        • 7.4.2.2.5. By Product
        • 7.4.2.2.6. By End-User
    • 7.4.3. Canada Proteomics Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Application
        • 7.4.3.2.2. By Indication
        • 7.4.3.2.3. By Technology
        • 7.4.3.2.4. By Type
        • 7.4.3.2.5. By Product
        • 7.4.3.2.6. By End-User

8. South America Proteomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Indication
    • 8.2.3. By Technology
    • 8.2.4. By Type
    • 8.2.5. By Product
    • 8.2.6. By End-User
    • 8.2.7. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. South America: Country Analysis
    • 8.4.1. Brazil Proteomics Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Application
        • 8.4.1.2.2. By Indication
        • 8.4.1.2.3. By Technology
        • 8.4.1.2.4. By Type
        • 8.4.1.2.5. By Product
        • 8.4.1.2.6. By End-User
    • 8.4.2. Argentina Proteomics Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Application
        • 8.4.2.2.2. By Indication
        • 8.4.2.2.3. By Technology
        • 8.4.2.2.4. By Type
        • 8.4.2.2.5. By Product
        • 8.4.2.2.6. By End-User
    • 8.4.3. Colombia Proteomics Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Application
        • 8.4.3.2.2. By Indication
        • 8.4.3.2.3. By Technology
        • 8.4.3.2.4. By Type
        • 8.4.3.2.5. By Product
        • 8.4.3.2.6. By End-User

9. Middle East and Africa Proteomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Indication
    • 9.2.3. By Technology
    • 9.2.4. By Type
    • 9.2.5. By Product
    • 9.2.6. By End-User
    • 9.2.7. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. MEA: Country Analysis
    • 9.4.1. South Africa Proteomics Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Application
        • 9.4.1.2.2. By Indication
        • 9.4.1.2.3. By Technology
        • 9.4.1.2.4. By Type
        • 9.4.1.2.5. By Product
        • 9.4.1.2.6. By End-User
    • 9.4.2. Saudi Arabia Proteomics Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Application
        • 9.4.2.2.2. By Indication
        • 9.4.2.2.3. By Technology
        • 9.4.2.2.4. By Type
        • 9.4.2.2.5. By Product
        • 9.4.2.2.6. By End-User
    • 9.4.3. UAE Proteomics Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Application
        • 9.4.3.2.2. By Indication
        • 9.4.3.2.3. By Technology
        • 9.4.3.2.4. By Type
        • 9.4.3.2.5. By Product
        • 9.4.3.2.6. By End-User

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

12. Competitive Landscape

  • 12.1. Competition Outlook
  • 12.2. Players Profiled (Leading Companies)
    • 12.2.1. Thermo Fisher Scientific
    • 12.2.2. Agilent Technologies
    • 12.2.3. Waters Corporation
    • 12.2.4. Bio-Rad Laboratories
    • 12.2.5. GE Healthcare
    • 12.2.6. PerkinElmer
    • 12.2.7. Creative Proteomics
    • 12.2.8. Luminex Corporation
    • 12.2.9. Promega Corporation
    • 12.2.10. Caprion
    • 12.2.11. Bruker
    • 12.2.12. Pfizer
    • 12.2.13. Horiba
    • 12.2.14. Qiagen
    • 12.2.15. Becton Dickinson
    • 12.2.16. Bioproximity
    • 12.2.17. Biocon
    • 12.2.18. Evotec
    • 12.2.19. Bristol-Myers Squibb
    • 12.2.20. Illumina
    • 12.2.21. Takeda Pharmaceuticals

13. Strategic Recommendations

14. About Us & Disclaimer

Back to Top
전화 문의
F A Q